BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3371425)

  • 1. Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis.
    Laskey J; Webb I; Schulman HM; Ponka P
    Exp Cell Res; 1988 May; 176(1):87-95. PubMed ID: 3371425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-receptor-independent but iron-dependent proliferation of variant Chinese hamster ovary cells.
    Chan RY; Ponka P; Schulman HM
    Exp Cell Res; 1992 Oct; 202(2):326-36. PubMed ID: 1397086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of heme synthesis during Friend cell differentiation: role of iron and transferrin.
    Laskey JD; Ponka P; Schulman HM
    J Cell Physiol; 1986 Nov; 129(2):185-92. PubMed ID: 3464611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferric-salicylaldehyde isonicotinoyl hydrazone, a synthetic iron chelate, alleviates defective iron utilization by reticulocytes of the Belgrade rat.
    Garrick LM; Gniecko K; Hoke JE; al-Nakeeb A; Ponka P; Garrick MD
    J Cell Physiol; 1991 Mar; 146(3):460-5. PubMed ID: 2022700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential fatty acids and iron are involved at distinct stages of the proliferative cycle but not in the activation of human T cells.
    Or R; Kovar J; Domenico J; Gelfand EW
    Clin Immunol Immunopathol; 1992 Mar; 62(3):314-20. PubMed ID: 1371729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lipophilic iron chelator induces an enhanced proliferation of human erythroleukaemia (HEL) cells.
    Ekblom P; Landschulz W; Andersson LC
    Scand J Haematol; 1986 Mar; 36(3):258-62. PubMed ID: 3458297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin and transferrin receptor function in brain barrier systems.
    Moos T; Morgan EH
    Cell Mol Neurobiol; 2000 Feb; 20(1):77-95. PubMed ID: 10690503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of growth of cultured hepatic epithelial cells by transferrin.
    Tsao MS; Sanders GH; Grisham JW
    Exp Cell Res; 1987 Jul; 171(1):52-62. PubMed ID: 3305046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine.
    Thorson JA; Smith KM; Gomez F; Naumann PW; Kemp JD
    Cell Immunol; 1991 Apr; 134(1):126-37. PubMed ID: 1826464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the transferrin receptor for the activation of human lymphocytes.
    Keyna U; Nüsslein I; Rohwer P; Kalden JR; Manger B
    Cell Immunol; 1991 Feb; 132(2):411-22. PubMed ID: 1988160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
    Taetle R; Castagnola J; Mendelsohn J
    Cancer Res; 1986 Apr; 46(4 Pt 1):1759-63. PubMed ID: 3004704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin and iron requirements of embryonic mesoderm cells cultured in hydrated collagen matrices.
    Sanders EJ; Cheung E
    In Vitro Cell Dev Biol; 1988 Jun; 24(6):581-7. PubMed ID: 3391934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of transferrin receptors and their relationship to cell growth.
    Trowbridge IS; Shackelford DA
    Biochem Soc Symp; 1986; 51():117-29. PubMed ID: 3545211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis.
    Furukawa T; Naitoh Y; Kohno H; Tokunaga R; Taketani S
    Life Sci; 1992; 50(26):2059-65. PubMed ID: 1608289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments.
    Lesley J; Schulte R; Woods J
    Exp Cell Res; 1989 May; 182(1):215-33. PubMed ID: 2653853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prooxidant and antioxidant properties of salicylaldehyde isonicotinoyl hydrazone iron chelators in HepG2 cells.
    Caro AA; Commissariat A; Dunn C; Kim H; García SL; Smith A; Strang H; Stuppy J; Desrochers LP; Goodwin TE
    Biochim Biophys Acta; 2015 Nov; 1850(11):2256-64. PubMed ID: 26275495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of transferrin in serum-free cultures of mitogen-stimulated mouse lymphocytes by a lipophilic iron chelator.
    Brock JH; Stevenson J
    Immunol Lett; 1987 May; 15(1):23-5. PubMed ID: 3610230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways.
    Seligman PA; Kovar J; Gelfand EW
    Pathobiology; 1992; 60(1):19-26. PubMed ID: 1543546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of macrophage proliferation by anti-transferrin receptor antibody ER-MP21: correlation to macrophage differentiation stage.
    Leenen PJ; Kroos MJ; Melis M; Slieker WA; van Ewijk W; van Eijk HG
    Exp Cell Res; 1990 Jul; 189(1):55-63. PubMed ID: 2189739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.